RNAZ TRANSCODE THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Securities Purchase Agreement TransCode Therapeutics, Inc. entered into a Securities Purchase Agreement to sell 2,846,300 shares of common stock at a purchase price of $0.527 per share, for gross proceeds of approximately $1.5 million.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC